MAB-CHMINACA

NameMAB-CHMINACA
Formal NameN-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide ; ADBCHMINACA
SMILESNC(=O)C(NC(=O)c3nn(CC1CCCCC1)c2ccccc23)C(C)(C)C
InChI KeyZWCCSIUBHCZKOY-UHFFFAOYAP
InChI CodeInChI=1/C21H30N4O2/c1-21(2,3)18(19(22)26)23-20(27)17-15-11-7-8-12-16(15)25(24- 17)13-14-9-5-4-6-10-14/h7-8,11-12,14,18H,4-6,9-10,13H2,1-3H3,(H2,22,26)(H,23,27)
DescriptionMAB-CHMINACA is a synthetic cannabinoid designer drug that is structurally similar to ABCHMINACA, differing by the replacement of the isopropyl group in the 2-amino primary amide side chain with a tert-butyl group. The single (S)-enantiomer of MAB-CHMINACA is a high affinity ligand of the CB1 receptor (Ki = 0.289 nM). It was first observed on illicit Internet drug sites in August of 2014, and has recently been identified in samples of dubious herbal products. While the physiological and toxicological properties of this compound have not yet been reported, MAB-CHMINACA, in conjunction with 5-fluoro-ADB, has been cited in one postmortem examination as exerting toxicity leading to death after a short interval.

Status

Verified
Submitted2015-03-03
Submitted ByCayman Chemical
Miami Valley Regional Crime Laboratory, Dayton, Ohio
Published2015-06-08
ContactPaul D. Kennedy, PhD. at Cayman Chemical
Product DetailsLink

Monograph

Download the MAB-CHMINACA Monograph